NeuroOne Medical Technologies Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for NeuroOne Medical Technologies Corporation (NMTC) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Sep 2024Sep 2023Sep 2022Sep 2021
Current Assets
Cash and Cash Equivalents6.571.465.3211.146.90
Short-Term Investments0.000.000.002.980.00
Cash & Short-Term Investments6.571.465.3211.146.90
Accounts Receivable1.260.180.000.030.05
Inventory2.232.641.730.700.10
Other Current Assets0.160.220.260.300.15
Total Current Assets10.234.637.3112.187.29
Non-Current Assets
Property, Plant & Equipment (Net)0.510.670.690.530.51
Intangible Assets0.040.070.090.110.13
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.560.740.780.650.65
Total Assets10.795.378.1012.827.94
Current Liabilities
Accounts Payable1.011.030.691.641.17
Short-Term Debt0.120.000.000.000.00
Accrued Liabilities1.171.060.980.630.53
Deferred Revenue0.000.000.001.460.01
Other Current Liabilities1.170.060.000.520.38
Total Current Liabilities2.302.211.793.101.18
Non-Current Liabilities
Long-Term Debt0.140.190.060.120.20
Other Non-Current Liabilities1.272.140.000.000.00
Total Non-Current Liabilities1.412.330.060.120.20
Total Liabilities3.714.551.853.221.38
Stockholders' Equity
Common Stock0.050.030.020.020.01
Retained Earnings-78.61-75.00-62.69-50.83-40.83
Additional Paid-in Capital85.6375.8068.9160.4147.37
Shares Outstanding50.0130.8223.9316.220.00
Total Stockholders' Equity7.070.826.259.606.55
Total Liabilities & Equity10.795.378.1012.827.94